gliclazide has been researched along with Dermatitis, Exfoliative in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Dermatitis, Exfoliative: The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Erythroderma is generalized exfoliative dermatitis, which involves more than 90% of the patient's skin." | 1.40 | Erythroderma secondary to gliclazide: a case report. ( Kacar, SD; Karaca, S; Ozuguz, P; Ozuguz, U; Tokyol, C, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ozuguz, P | 1 |
Kacar, SD | 1 |
Ozuguz, U | 1 |
Karaca, S | 1 |
Tokyol, C | 1 |
1 other study available for gliclazide and Dermatitis, Exfoliative
Article | Year |
---|---|
Erythroderma secondary to gliclazide: a case report.
Topics: Aged; Dermatitis, Exfoliative; Drug Eruptions; Female; Gliclazide; Humans; Hyperglycemia; Hypoglycem | 2014 |